- On-demand
- About
As COVID-19 becomes a more distant memory, insurers' attention has shifted to other things. But, the reality is that the risk of future mortality shocks and their impacts are still with us. This session will discuss how the COVID-19 mortality experience and response along with advances in modeling can help quantify excess mortality risks through the new Moody's RMS Infectious Disease Model. With the ability of the Infectious Disease Model to estimate lockdown and downtime in addition to pandemic mortality and morbidity, this is relevant for P&C as well as life and health insurers.
-
Speakers
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign In
Please sign in to your account: